Raphael Pharmaceutical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2020 - 2019
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2020 - 2019
Cash & Equivalents	0.05	0.02	0.23	0.29	0.15	Upgrade
Cash & Short-Term Investments	0.05	0.02	0.23	0.29	0.15	Upgrade
Cash Growth	136.84%	-91.74%	-20.14%	88.23%	61.05%	Upgrade
Other Receivables	0	0	0.01	0.04	0.09	Upgrade
Receivables	0	0	0.01	0.04	0.09	Upgrade
Prepaid Expenses	0	0	-	0.01	0.18	Upgrade
Total Current Assets	0.05	0.03	0.24	0.33	0.42	Upgrade
Property, Plant & Equipment	0	0	0	0	-	Upgrade
Total Assets	0.05	0.03	0.24	0.33	0.42	Upgrade
Accounts Payable	0.16	0.13	0.07	0.07	0.11	Upgrade
Accrued Expenses	1.29	0.6	0.06	0.16	0.19	Upgrade
Short-Term Debt	0.03	0.04	-	-	-	Upgrade
Total Current Liabilities	1.49	0.77	0.13	0.23	0.29	Upgrade
Total Liabilities	1.49	0.77	0.13	0.23	0.29	Upgrade
Common Stock	0.2	0.19	0.19	0.16	0.13	Upgrade
Additional Paid-In Capital	8.53	7.96	7.39	5.98	2.67	Upgrade
Retained Earnings	-10.17	-8.89	-7.37	-6.03	-2.67	Upgrade
Comprehensive Income & Other	-	-	-0.1	-	-	Upgrade
Shareholders' Equity	-1.43	-0.74	0.11	0.11	0.13	Upgrade
Total Liabilities & Equity	0.05	0.03	0.24	0.33	0.42	Upgrade
Total Debt	0.03	0.04	-	-	-	Upgrade
Net Cash (Debt)	0.01	-0.02	0.23	0.29	0.15	Upgrade
Net Cash Growth	-	-	-20.14%	88.23%	-	Upgrade
Net Cash Per Share	0.00	-0.00	0.01	0.02	0.01	Upgrade
Filing Date Shares Outstanding	20.18	19.63	18.66	16.14	12.97	Upgrade
Total Common Shares Outstanding	20.18	18.7	18.5	15.62	12.97	Upgrade
Working Capital	-1.44	-0.74	0.11	0.1	0.13	Upgrade
Book Value Per Share	-0.07	-0.04	0.01	0.01	0.01	Upgrade
Tangible Book Value	-1.43	-0.74	0.11	0.11	0.13	Upgrade
Tangible Book Value Per Share	-0.07	-0.04	0.01	0.01	0.01	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.